Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents

dc.contributor.authorGenc, Murat
dc.contributor.authorGenc, Zuhal Karagoz
dc.contributor.authorTekin, Suat
dc.contributor.authorSandal, Suleyman
dc.contributor.authorSirajuddin, Muhammad
dc.contributor.authorBen Hadda, Taibi
dc.contributor.authorSekerci, Memet
dc.date.accessioned2026-08-12T17:17:04Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractThis article demonstrates the synthesis of 1,2,4-triazole derivatives and their applications in medicine particularly as anti-breast cancer agents which is a major issue of the present. The synthesized compounds were characterized by elemental analysis, FT-IR and NMR. DFT was used to study the quantum chemical calculations of geometries and vibrational wave numbers of 3-hydroxynaphthyl and p-tolyl substituted 1,2,4-triazoles in the ground state. The scaled harmonic vibrational frequencies obtained from the DFT method were compared with those of the FT-IR spectra and found good agreement. The synthesized 1,2,4-triazole-naphthyl hybrids were screened for the anticancer activity against MCF-7 breast cancer lines. Among them compounds 3 and 7 showed broad spectrum anticancer activity with IC50 values 9.7 mu M and 7.10 mu M, respectively and their activity is comparable to that of the standard drugs. The molecular model for binding between the compounds (1-8) and the active site of BRCA2 was obtained on the basis of the computational docking results and the structure-activity relationship.
dc.description.sponsorshipAdiyaman University Research Foundation [FEFAAP/2012-0001]
dc.description.sponsorshipWe are indebted to the Adiyaman University Research Foundation (FEFAAP/2012-0001) for financial support of this work.
dc.identifier.doi10.17344/acsi.2016.2428
dc.identifier.endpage737
dc.identifier.issn1318-0207
dc.identifier.issn1580-3155
dc.identifier.issue4
dc.identifier.orcid0000-0002-5633-6203
dc.identifier.orcid0000-0003-1224-4128
dc.identifier.orcid0000-0002-2757-1802
dc.identifier.orcid0000-0002-1147-1284
dc.identifier.pmid28004087
dc.identifier.scopus2-s2.0-85004097356
dc.identifier.scopusqualityQ3
dc.identifier.startpage726
dc.identifier.urihttps://doi.org/10.17344/acsi.2016.2428
dc.identifier.urihttps://hdl.handle.net/11508/52530
dc.identifier.volume63
dc.identifier.wosWOS:000392743500006
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSlovensko Kemijsko Drustvo
dc.relation.ispartofActa Chimica Slovenica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subject1,2,4-triazoles
dc.subjectDocking
dc.subjectDFT
dc.subjectPOM Analysis
dc.subjectBreast cancer
dc.titleDesign, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents
dc.typeArticle

Dosyalar